137 related articles for article (PubMed ID: 11955468)
1. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women.
Yaffe K; Lui LY; Grady D; Stone K; Morin P
Biol Psychiatry; 2002 Apr; 51(8):677-82. PubMed ID: 11955468
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.
Yaffe K; Lindquist K; Sen S; Cauley J; Ferrell R; Penninx B; Harris T; Li R; Cummings SR
Neurobiol Aging; 2009 Apr; 30(4):607-14. PubMed ID: 17889406
[TBL] [Abstract][Full Text] [Related]
3. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.
Corbo RM; Gambina G; Ruggeri M; Scacchi R
Dement Geriatr Cogn Disord; 2006; 22(1):67-72. PubMed ID: 16699281
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor 1 PvuII and XbaI polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
Lee YH; Song GG
Genet Mol Res; 2015 Aug; 14(3):9361-9. PubMed ID: 26345870
[TBL] [Abstract][Full Text] [Related]
5. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures.
Lui LY; Stone K; Cauley JA; Hillier T; Yaffe K
J Am Geriatr Soc; 2003 Jan; 51(1):38-43. PubMed ID: 12534843
[TBL] [Abstract][Full Text] [Related]
6. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women.
Mattila KM; Axelman K; Rinne JO; Blomberg M; Lehtimäki T; Laippala P; Röyttä M; Viitanen M; Wahlund L; Winblad B; Lannfelt L
Neurosci Lett; 2000 Mar; 282(1-2):45-8. PubMed ID: 10713392
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women.
Olsen L; Rasmussen HB; Hansen T; Bagger YZ; Tankó LB; Qin G; Christiansen C; Werge T
Psychiatr Genet; 2006 Apr; 16(2):85-8. PubMed ID: 16538187
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
9. Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.
Ryan J; Carrière I; Amieva H; Rouaud O; Berr C; Ritchie K; Scarabin PY; Ancelin ML
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1763-8. PubMed ID: 23932494
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction.
Schuit SC; Oei HH; Witteman JC; Geurts van Kessel CH; van Meurs JB; Nijhuis RL; van Leeuwen JP; de Jong FH; Zillikens MC; Hofman A; Pols HA; Uitterlinden AG
JAMA; 2004 Jun; 291(24):2969-77. PubMed ID: 15213208
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia.
Ji Y; Urakami K; Wada-Isoe K; Adachi Y; Nakashima K
Dement Geriatr Cogn Disord; 2000; 11(3):119-22. PubMed ID: 10765041
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.
Ma SL; Tang NL; Leung GT; Fung AW; Lam LC
Am J Geriatr Psychiatry; 2014 May; 22(5):489-98. PubMed ID: 23567436
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study.
Yaffe K; Blackwell T; Gore R; Sands L; Reus V; Browner WS
Arch Gen Psychiatry; 1999 May; 56(5):425-30. PubMed ID: 10232297
[TBL] [Abstract][Full Text] [Related]
14. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations.
Yaffe K; Lui LY; Grady D; Cauley J; Kramer J; Cummings SR
Lancet; 2000 Aug; 356(9231):708-12. PubMed ID: 11085689
[TBL] [Abstract][Full Text] [Related]
15. Preclinical cognitive decline and subsequent sleep disturbance in older women.
Yaffe K; Blackwell T; Barnes DE; Ancoli-Israel S; Stone KL;
Neurology; 2007 Jul; 69(3):237-42. PubMed ID: 17636060
[TBL] [Abstract][Full Text] [Related]
16. PvuII and XbaI polymorphisms of the estrogen receptor gene and bone mineral density in a Bulgarian population sample.
Ivanova JT; Doukova PB; Boyanov MA; Popivanov PR
Hormones (Athens); 2007; 6(1):36-43. PubMed ID: 17324916
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of physical activity and cognitive decline in elderly women: women who walk.
Yaffe K; Barnes D; Nevitt M; Lui LY; Covinsky K
Arch Intern Med; 2001 Jul; 161(14):1703-8. PubMed ID: 11485502
[TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy and cognitive decline in older community women.
Matthews K; Cauley J; Yaffe K; Zmuda JM
J Am Geriatr Soc; 1999 May; 47(5):518-23. PubMed ID: 10323642
[TBL] [Abstract][Full Text] [Related]
19. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
20. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
